 | • レポートコード：MRC2-11QY12310 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は免疫介在性炎症性疾患治療のグローバル市場について調査・分析したレポートです。種類別（標的化生物学的療法、新治療法）市場規模、用途別（病院、薬局、オンライン薬局）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別免疫介在性炎症性疾患治療の競争状況、市場シェア ・世界の免疫介在性炎症性疾患治療市場：種類別市場規模 2015年-2020年（標的化生物学的療法、新治療法） ・世界の免疫介在性炎症性疾患治療市場：種類別市場規模予測 2021年-2026年（標的化生物学的療法、新治療法） ・世界の免疫介在性炎症性疾患治療市場：用途別市場規模 2015年-2020年（病院、薬局、オンライン薬局） ・世界の免疫介在性炎症性疾患治療市場：用途別市場規模予測 2021年-2026年（病院、薬局、オンライン薬局） ・北米の免疫介在性炎症性疾患治療市場分析：米国、カナダ ・ヨーロッパの免疫介在性炎症性疾患治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの免疫介在性炎症性疾患治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の免疫介在性炎症性疾患治療市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの免疫介在性炎症性疾患治療市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：GlaxoSmithKline、Eli Lilly、AstraZeneca、Bristol-Myers、Sanofi、Roche、Enlivex Therapeutics、Immune Pharmaceuticals、Tanabe Pharma ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Immune-Mediated Inflammatory Diseases Treatment is any of a group of conditions or diseases that lack a definitive etiology, but which are characterized by common inflammatory pathways leading to inflammation, and which may result from, or be triggered by, a dysregulation of the normal immune response.
Market Analysis and Insights: Global Immune-Mediated Inflammatory Diseases Treatment Market
The global Immune-Mediated Inflammatory Diseases Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Immune-Mediated Inflammatory Diseases Treatment Scope and Market Size
Immune-Mediated Inflammatory Diseases Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Immune-Mediated Inflammatory Diseases Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
GlaxoSmithKline
Eli Lilly
AstraZeneca
Bristol-Myers
Sanofi
Roche
Enlivex Therapeutics
Immune Pharmaceuticals
Tanabe Pharma
Market segment by Type, the product can be split into
Targeted biologic therapies
Novel therapies
Market segment by Application, split into
Hospitals
Pharmacy Store
Online Pharmacy
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Immune-Mediated Inflammatory Diseases Treatment Revenue
1.4 Market by Type
1.4.1 Global Immune-Mediated Inflammatory Diseases Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Targeted biologic therapies
1.4.3 Novel therapies
1.5 Market by Application
1.5.1 Global Immune-Mediated Inflammatory Diseases Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Pharmacy Store
1.5.4 Online Pharmacy
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Immune-Mediated Inflammatory Diseases Treatment Market Perspective (2015-2026)
2.2 Global Immune-Mediated Inflammatory Diseases Treatment Growth Trends by Regions
2.2.1 Immune-Mediated Inflammatory Diseases Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Immune-Mediated Inflammatory Diseases Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Immune-Mediated Inflammatory Diseases Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Immune-Mediated Inflammatory Diseases Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Immune-Mediated Inflammatory Diseases Treatment Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Immune-Mediated Inflammatory Diseases Treatment Players by Market Size
3.1.1 Global Top Immune-Mediated Inflammatory Diseases Treatment Players by Revenue (2015-2020)
3.1.2 Global Immune-Mediated Inflammatory Diseases Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Immune-Mediated Inflammatory Diseases Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Immune-Mediated Inflammatory Diseases Treatment Market Concentration Ratio
3.2.1 Global Immune-Mediated Inflammatory Diseases Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Immune-Mediated Inflammatory Diseases Treatment Revenue in 2019
3.3 Immune-Mediated Inflammatory Diseases Treatment Key Players Head office and Area Served
3.4 Key Players Immune-Mediated Inflammatory Diseases Treatment Product Solution and Service
3.5 Date of Enter into Immune-Mediated Inflammatory Diseases Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Immune-Mediated Inflammatory Diseases Treatment Historic Market Size by Type (2015-2020)
4.2 Global Immune-Mediated Inflammatory Diseases Treatment Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2015-2020)
5.2 Global Immune-Mediated Inflammatory Diseases Treatment Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Immune-Mediated Inflammatory Diseases Treatment Market Size (2015-2020)
6.2 Immune-Mediated Inflammatory Diseases Treatment Key Players in North America (2019-2020)
6.3 North America Immune-Mediated Inflammatory Diseases Treatment Market Size by Type (2015-2020)
6.4 North America Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2015-2020)
7 Europe
7.1 Europe Immune-Mediated Inflammatory Diseases Treatment Market Size (2015-2020)
7.2 Immune-Mediated Inflammatory Diseases Treatment Key Players in Europe (2019-2020)
7.3 Europe Immune-Mediated Inflammatory Diseases Treatment Market Size by Type (2015-2020)
7.4 Europe Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2015-2020)
8 China
8.1 China Immune-Mediated Inflammatory Diseases Treatment Market Size (2015-2020)
8.2 Immune-Mediated Inflammatory Diseases Treatment Key Players in China (2019-2020)
8.3 China Immune-Mediated Inflammatory Diseases Treatment Market Size by Type (2015-2020)
8.4 China Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2015-2020)
9 Japan
9.1 Japan Immune-Mediated Inflammatory Diseases Treatment Market Size (2015-2020)
9.2 Immune-Mediated Inflammatory Diseases Treatment Key Players in Japan (2019-2020)
9.3 Japan Immune-Mediated Inflammatory Diseases Treatment Market Size by Type (2015-2020)
9.4 Japan Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Immune-Mediated Inflammatory Diseases Treatment Market Size (2015-2020)
10.2 Immune-Mediated Inflammatory Diseases Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Immune-Mediated Inflammatory Diseases Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2015-2020)
11 India
11.1 India Immune-Mediated Inflammatory Diseases Treatment Market Size (2015-2020)
11.2 Immune-Mediated Inflammatory Diseases Treatment Key Players in India (2019-2020)
11.3 India Immune-Mediated Inflammatory Diseases Treatment Market Size by Type (2015-2020)
11.4 India Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Immune-Mediated Inflammatory Diseases Treatment Market Size (2015-2020)
12.2 Immune-Mediated Inflammatory Diseases Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Immune-Mediated Inflammatory Diseases Treatment Market Size by Type (2015-2020)
12.4 Central & South America Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 GlaxoSmithKline
13.1.1 GlaxoSmithKline Company Details
13.1.2 GlaxoSmithKline Business Overview
13.1.3 GlaxoSmithKline Immune-Mediated Inflammatory Diseases Treatment Introduction
13.1.4 GlaxoSmithKline Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2015-2020))
13.1.5 GlaxoSmithKline Recent Development
13.2 Eli Lilly
13.2.1 Eli Lilly Company Details
13.2.2 Eli Lilly Business Overview
13.2.3 Eli Lilly Immune-Mediated Inflammatory Diseases Treatment Introduction
13.2.4 Eli Lilly Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2015-2020)
13.2.5 Eli Lilly Recent Development
13.3 AstraZeneca
13.3.1 AstraZeneca Company Details
13.3.2 AstraZeneca Business Overview
13.3.3 AstraZeneca Immune-Mediated Inflammatory Diseases Treatment Introduction
13.3.4 AstraZeneca Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2015-2020)
13.3.5 AstraZeneca Recent Development
13.4 Bristol-Myers
13.4.1 Bristol-Myers Company Details
13.4.2 Bristol-Myers Business Overview
13.4.3 Bristol-Myers Immune-Mediated Inflammatory Diseases Treatment Introduction
13.4.4 Bristol-Myers Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2015-2020)
13.4.5 Bristol-Myers Recent Development
13.5 Sanofi
13.5.1 Sanofi Company Details
13.5.2 Sanofi Business Overview
13.5.3 Sanofi Immune-Mediated Inflammatory Diseases Treatment Introduction
13.5.4 Sanofi Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2015-2020)
13.5.5 Sanofi Recent Development
13.6 Roche
13.6.1 Roche Company Details
13.6.2 Roche Business Overview
13.6.3 Roche Immune-Mediated Inflammatory Diseases Treatment Introduction
13.6.4 Roche Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2015-2020)
13.6.5 Roche Recent Development
13.7 Enlivex Therapeutics
13.7.1 Enlivex Therapeutics Company Details
13.7.2 Enlivex Therapeutics Business Overview
13.7.3 Enlivex Therapeutics Immune-Mediated Inflammatory Diseases Treatment Introduction
13.7.4 Enlivex Therapeutics Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2015-2020)
13.7.5 Enlivex Therapeutics Recent Development
13.8 Immune Pharmaceuticals
13.8.1 Immune Pharmaceuticals Company Details
13.8.2 Immune Pharmaceuticals Business Overview
13.8.3 Immune Pharmaceuticals Immune-Mediated Inflammatory Diseases Treatment Introduction
13.8.4 Immune Pharmaceuticals Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2015-2020)
13.8.5 Immune Pharmaceuticals Recent Development
13.9 Tanabe Pharma
13.9.1 Tanabe Pharma Company Details
13.9.2 Tanabe Pharma Business Overview
13.9.3 Tanabe Pharma Immune-Mediated Inflammatory Diseases Treatment Introduction
13.9.4 Tanabe Pharma Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2015-2020)
13.9.5 Tanabe Pharma Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Immune-Mediated Inflammatory Diseases Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Immune-Mediated Inflammatory Diseases Treatment Revenue
Table 3. Ranking of Global Top Immune-Mediated Inflammatory Diseases Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Immune-Mediated Inflammatory Diseases Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Targeted biologic therapies
Table 6. Key Players of Novel therapies
Table 7. Global Immune-Mediated Inflammatory Diseases Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Immune-Mediated Inflammatory Diseases Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Immune-Mediated Inflammatory Diseases Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Immune-Mediated Inflammatory Diseases Treatment Market Share by Regions (2015-2020)
Table 11. Global Immune-Mediated Inflammatory Diseases Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Immune-Mediated Inflammatory Diseases Treatment Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Immune-Mediated Inflammatory Diseases Treatment Market Growth Strategy
Table 17. Main Points Interviewed from Key Immune-Mediated Inflammatory Diseases Treatment Players
Table 18. Global Immune-Mediated Inflammatory Diseases Treatment Revenue by Players (2015-2020) (Million US$)
Table 19. Global Immune-Mediated Inflammatory Diseases Treatment Market Share by Players (2015-2020)
Table 20. Global Top Immune-Mediated Inflammatory Diseases Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Immune-Mediated Inflammatory Diseases Treatment as of 2019)
Table 21. Global Immune-Mediated Inflammatory Diseases Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Immune-Mediated Inflammatory Diseases Treatment Product Solution and Service
Table 24. Date of Enter into Immune-Mediated Inflammatory Diseases Treatment Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Immune-Mediated Inflammatory Diseases Treatment Market Size by Type (2015-2020) (Million US$)
Table 27. Global Immune-Mediated Inflammatory Diseases Treatment Market Size Share by Type (2015-2020)
Table 28. Global Immune-Mediated Inflammatory Diseases Treatment Revenue Market Share by Type (2021-2026)
Table 29. Global Immune-Mediated Inflammatory Diseases Treatment Market Size Share by Application (2015-2020)
Table 30. Global Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2015-2020) (Million US$)
Table 31. Global Immune-Mediated Inflammatory Diseases Treatment Market Size Share by Application (2021-2026)
Table 32. North America Key Players Immune-Mediated Inflammatory Diseases Treatment Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Immune-Mediated Inflammatory Diseases Treatment Market Share (2019-2020)
Table 34. North America Immune-Mediated Inflammatory Diseases Treatment Market Size by Type (2015-2020) (Million US$)
Table 35. North America Immune-Mediated Inflammatory Diseases Treatment Market Share by Type (2015-2020)
Table 36. North America Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2015-2020) (Million US$)
Table 37. North America Immune-Mediated Inflammatory Diseases Treatment Market Share by Application (2015-2020)
Table 38. Europe Key Players Immune-Mediated Inflammatory Diseases Treatment Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Immune-Mediated Inflammatory Diseases Treatment Market Share (2019-2020)
Table 40. Europe Immune-Mediated Inflammatory Diseases Treatment Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Immune-Mediated Inflammatory Diseases Treatment Market Share by Type (2015-2020)
Table 42. Europe Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Immune-Mediated Inflammatory Diseases Treatment Market Share by Application (2015-2020)
Table 44. China Key Players Immune-Mediated Inflammatory Diseases Treatment Revenue (2019-2020) (Million US$)
Table 45. China Key Players Immune-Mediated Inflammatory Diseases Treatment Market Share (2019-2020)
Table 46. China Immune-Mediated Inflammatory Diseases Treatment Market Size by Type (2015-2020) (Million US$)
Table 47. China Immune-Mediated Inflammatory Diseases Treatment Market Share by Type (2015-2020)
Table 48. China Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2015-2020) (Million US$)
Table 49. China Immune-Mediated Inflammatory Diseases Treatment Market Share by Application (2015-2020)
Table 50. Japan Key Players Immune-Mediated Inflammatory Diseases Treatment Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Immune-Mediated Inflammatory Diseases Treatment Market Share (2019-2020)
Table 52. Japan Immune-Mediated Inflammatory Diseases Treatment Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Immune-Mediated Inflammatory Diseases Treatment Market Share by Type (2015-2020)
Table 54. Japan Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Immune-Mediated Inflammatory Diseases Treatment Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Immune-Mediated Inflammatory Diseases Treatment Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Immune-Mediated Inflammatory Diseases Treatment Market Share (2019-2020)
Table 58. Southeast Asia Immune-Mediated Inflammatory Diseases Treatment Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Immune-Mediated Inflammatory Diseases Treatment Market Share by Type (2015-2020)
Table 60. Southeast Asia Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Immune-Mediated Inflammatory Diseases Treatment Market Share by Application (2015-2020)
Table 62. India Key Players Immune-Mediated Inflammatory Diseases Treatment Revenue (2019-2020) (Million US$)
Table 63. India Key Players Immune-Mediated Inflammatory Diseases Treatment Market Share (2019-2020)
Table 64. India Immune-Mediated Inflammatory Diseases Treatment Market Size by Type (2015-2020) (Million US$)
Table 65. India Immune-Mediated Inflammatory Diseases Treatment Market Share by Type (2015-2020)
Table 66. India Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2015-2020) (Million US$)
Table 67. India Immune-Mediated Inflammatory Diseases Treatment Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Immune-Mediated Inflammatory Diseases Treatment Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Immune-Mediated Inflammatory Diseases Treatment Market Share (2019-2020)
Table 70. Central & South America Immune-Mediated Inflammatory Diseases Treatment Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Immune-Mediated Inflammatory Diseases Treatment Market Share by Type (2015-2020)
Table 72. Central & South America Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Immune-Mediated Inflammatory Diseases Treatment Market Share by Application (2015-2020)
Table 74. GlaxoSmithKline Company Details
Table 75. GlaxoSmithKline Business Overview
Table 76. GlaxoSmithKline Product
Table 77. GlaxoSmithKline Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2015-2020) (Million US$)
Table 78. GlaxoSmithKline Recent Development
Table 79. Eli Lilly Company Details
Table 80. Eli Lilly Business Overview
Table 81. Eli Lilly Product
Table 82. Eli Lilly Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2015-2020) (Million US$)
Table 83. Eli Lilly Recent Development
Table 84. AstraZeneca Company Details
Table 85. AstraZeneca Business Overview
Table 86. AstraZeneca Product
Table 87. AstraZeneca Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2015-2020) (Million US$)
Table 88. AstraZeneca Recent Development
Table 89. Bristol-Myers Company Details
Table 90. Bristol-Myers Business Overview
Table 91. Bristol-Myers Product
Table 92. Bristol-Myers Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2015-2020) (Million US$)
Table 93. Bristol-Myers Recent Development
Table 94. Sanofi Company Details
Table 95. Sanofi Business Overview
Table 96. Sanofi Product
Table 97. Sanofi Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2015-2020) (Million US$)
Table 98. Sanofi Recent Development
Table 99. Roche Company Details
Table 100. Roche Business Overview
Table 101. Roche Product
Table 102. Roche Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2015-2020) (Million US$)
Table 103. Roche Recent Development
Table 104. Enlivex Therapeutics Company Details
Table 105. Enlivex Therapeutics Business Overview
Table 106. Enlivex Therapeutics Product
Table 107. Enlivex Therapeutics Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2015-2020) (Million US$)
Table 108. Enlivex Therapeutics Recent Development
Table 109. Immune Pharmaceuticals Business Overview
Table 110. Immune Pharmaceuticals Product
Table 111. Immune Pharmaceuticals Company Details
Table 112. Immune Pharmaceuticals Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2015-2020) (Million US$)
Table 113. Immune Pharmaceuticals Recent Development
Table 114. Tanabe Pharma Company Details
Table 115. Tanabe Pharma Business Overview
Table 116. Tanabe Pharma Product
Table 117. Tanabe Pharma Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2015-2020) (Million US$)
Table 118. Tanabe Pharma Recent Development
Table 119. Research Programs/Design for This Report
Table 120. Key Data Information from Secondary Sources
Table 121. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Immune-Mediated Inflammatory Diseases Treatment Market Share by Type: 2020 VS 2026
Figure 2. Targeted biologic therapies Features
Figure 3. Novel therapies Features
Figure 4. Global Immune-Mediated Inflammatory Diseases Treatment Market Share by Application: 2020 VS 2026
Figure 5. Hospitals Case Studies
Figure 6. Pharmacy Store Case Studies
Figure 7. Online Pharmacy Case Studies
Figure 8. Immune-Mediated Inflammatory Diseases Treatment Report Years Considered
Figure 9. Global Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Immune-Mediated Inflammatory Diseases Treatment Market Share by Regions: 2020 VS 2026
Figure 11. Global Immune-Mediated Inflammatory Diseases Treatment Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Immune-Mediated Inflammatory Diseases Treatment Market Share by Players in 2019
Figure 14. Global Top Immune-Mediated Inflammatory Diseases Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Immune-Mediated Inflammatory Diseases Treatment as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Immune-Mediated Inflammatory Diseases Treatment Revenue in 2019
Figure 16. North America Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Bottom-up and Top-down Approaches for This Report
Figure 24. Data Triangulation
Figure 25. Key Executives Interviewed
炎症性腸疾患（IBD）治療の世界市場（～2026年） Inflammatory bowel disease is a group of medical indication that causes chronic inflammation in the gastrointestinal tract. The inflammatory bowel disease mainly comprises of Ulcerative colitis and Crohn’s disease. The ulcerative colitis primarily affects the large intestine and anus and it causes t…- 希少性肺疾患治療の世界市場（～2026年） Orphan illnesses are those which are not generally looked into, those where particular medicines are not accessible, and those which may just be of restricted enthusiasm to researchers and specialists. Orphan lung diseases are exemplified by the purported disregarded infectious diseases, which are e…
- 運動ニューロン疾患治療の世界市場（～2026年） Market Analysis and Insights: Global Motor Neuron Diseases Treatment Market The global Motor Neuron Diseases Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Motor Neuron Diseases Treatment Scope and Market Si…
- 豚病治療の世界市場（～2026年） Swine diseases treatments help in improving health, increase production of livestock and prevent transmission of diseases among animals in a cost effective manner. The global swine diseases treatment market is driven by factors such as rapid changing pattern of diseases among the animals. Market Ana…
- 筋骨格系疾患治療の世界市場（～2026年） Musculoskeletal disorders (MSDs) are injuries or pain in the human musculoskeletal system, including the joints, ligaments, muscles, nerves, tendons, and structures that support limbs, neck and back. MSDs can arise from a sudden exertion (e.g., lifting a heavy object)[2], or they can arise from maki…